Compare F5 Inc (FFIV) vs Viatris Inc (VTRS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
F5 Inc vs Viatris Inc — how do they compare? F5 Inc trades at $414 (market cap $23.44B), while Viatris Inc trades at $16.28 (market cap $18.69B). The key difference: F5 Inc is the larger of the two by market cap, and Viatris Inc pays a 2.95% dividend while F5 Inc pays none. Which is the better fit depends on your goals.
| FFIV | VTRS | |
|---|---|---|
Market Cap | $23.44B | $18.69B |
Sector | Technology | Health |
52-Week High | $431.26 | $17.86 |
52-Week Low | $223.99 | $9.49 |
Enterprise Value | $22.08B | $30.80B |
Dividend Yield | — | 2.95% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About F5 Inc
F5 is a market leader in the application delivery controller market. The company sells products for networking traffic, security, and policy management. Its products ensure applications are safely routed in efficient manners within on-premises data centers and across cloud environments. More than half of its revenue is based on providing services, and its three customer verticals are enterprises, service providers, and government entities. The Seattle-based firm was incorporated in 1996 and generates sales globally.
Read more on FFIV →About Viatris Inc
Formed by the combination of Mylan and Pfizer's Upjohn business in 2020, Viatris is one of the world's largest generic drug manufacturers, with a substantial off-patent branded drug portfolio. Its portfolio consists of more than 1,400 molecules with penetration across most of the developed world and in select emerging markets. The company's branded drug portfolio consists of off-patent blockbuster drugs that continue to generate strong sales, including Lipitor, Norvasc, Lyrica, Viagra, and EpiPen. While global competition has facilitated the commodification of small-molecule generic drugs, the company has demonstrated an edge over peers in its ability to manufacture complex generics (for example, generic Advair and Copaxone).
Read more on VTRS →
